Logotype for ActiveOps Plc

ActiveOps (AOM) H2 2025 earnings summary

Event summary combining transcript, slides, and related documents.

Logotype for ActiveOps Plc

H2 2025 earnings summary

24 Feb, 2026

Executive summary

  • Achieved strong organic and double-digit revenue and ARR growth across all regions, with significant momentum in new customer acquisition and expansion within existing accounts.

  • SaaS-based business model provides high revenue assurance and recurring revenue visibility, with 88–90% of revenue from SaaS.

  • Completed the acquisition of Enlighten, expanding product capabilities and market reach, particularly in Australia and the U.S., adding $11m ARR and accelerating presence.

  • Strategic focus remains on operational excellence, product innovation, and scaling through both direct and indirect sales channels.

Financial highlights

  • Group revenue grew 15% year-over-year to £30.5m, with SaaS revenue up 13–14% and professional services/Training & Implementation up 23%.

  • Adjusted EBITDA was £2.5m, broadly in line with the previous year, with an 8% margin.

  • Gross margin remained strong at 83–84%, with SaaS margin at 87–88% and T&I margin at 57–58%.

  • Profit before tax reached £1.3m; EPS improved to 1.55p.

  • Cash at bank grew to just under £21m, a 17% increase year-over-year.

Outlook and guidance

  • Q1 trading is in line with board expectations, with continued strong momentum in new customer wins and expansion.

  • Significant opportunity to grow ARR within existing customer base, with TAM increasing to £900m ARR post-Enlighten acquisition.

  • Focus on integrating Enlighten, expanding sales capacity, and developing indirect sales channels.

  • Product roadmap includes launch of ControliQ Series 5 and convergence of platforms.

  • Targeting a balance of 30% growth and 10% profitability (Rule of 40 approach).

Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.
All investor relations material. One API.
Learn more